New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria

Omar Khoja,  Matthew Mulvey, Sarah Astill,  et. al. ,doi: https://doi.org/10.1101/2024.07.10.24310234 ABSTRACT Background New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that the…[...]

Read More

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

O'Kelly B 1,2, Vidal L 2, McHugh T 2, et. al. Brain, Behavior, & Immunity - Health, 03 Jul 2022, 24:100485, https://doi.org/10.1016/j.bbih.2022.100485 PMID: 35814187 PMCID: PMC9250701 Abstract  Background Up to 37.7% of patients experience symptoms beyond 12 weeks after…[...]

Read More

Consistency of inconsistency in long-COVID-19 pain symptoms persistency: A systematic review and meta-analysis

Oleg Kerzhner MD, Einat Berla MD, Meirav Har-Even MSc RD, Motti Ratmansky MD, Itay Goor-Aryeh MD, July 2023, https://doi.org/10.1111/papr.13277 Introduction Individuals recovering from acute COVID-19 episodes may continue to suffer from various ongoing symptoms,…[...]

Read More